Zhongzhi Pharmaceutical Holdings Limited released its earnings results on Aug 26, 2025. The company reported HK$0.011 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.011.

Is Zhongzhi Pharmaceutical Holdings Limited overvalued?

According to Wall Street analysts Zhongzhi Pharmaceutical Holdings Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Zhongzhi Pharmaceutical Holdings Limited pay dividends?

Zhongzhi Pharmaceutical Holdings Limited pays a Annually dividend of HK$0.05 which represents an annual dividend yield of 9.43%. See more information on Zhongzhi Pharmaceutical Holdings Limited dividends here

What is Zhongzhi Pharmaceutical Holdings Limited’s EPS estimate?

Zhongzhi Pharmaceutical Holdings Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Zhongzhi Pharmaceutical Holdings Limited have?

Zhongzhi Pharmaceutical Holdings Limited has 863,600,000 shares outstanding.

What happened to Zhongzhi Pharmaceutical Holdings Limited’s price movement after its last earnings report?

Zhongzhi Pharmaceutical Holdings Limited reported an EPS of HK$0.011 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.22%.

Which hedge fund is a major shareholder of Zhongzhi Pharmaceutical Holdings Limited?

Currently, no hedge funds are holding shares in HK:3737

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Zhongzhi Pharmaceutical Holdings Limited Stock Smart Score

Underperform

Technicals

Fundamentals

Return on Equity

1.87%

Trailing 12-Months

Asset Growth

-4.21%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Zhongzhi Pharmaceutical Holdings Limited

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through three segments: Pharmaceutical Manufacturing, Operation of Chain Pharmacies, and Operation of On-Line Pharmacies. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also manufacture and sale of food and Chinese herbs; property management; and pharmaceutical drugs, as well as offers detection and testing services. As of December 31, 2021, it operated 398 self-operated chain pharmacies, including 361 medical insurance designated pharmacies located in Zhongshan in the Guangdong Province under the Zeus brand. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.